News

KRAS is one of the most frequently mutated genes in cancer. Researchers expose its secret vulnerabilities, laying out a fresh blueprint for targeting ‘undruggable’ proteins.

Clinical trial results support further study of this psychedelic substance, administered with psychological support from trained therapists, in affected patients.

A new study finds that radiation therapy (RT) suppresses a key protein called bone morphogenetic protein and activin membrane-bound inhibitor (BAMBI) and activates immune suppressive cells.

Ultrafast laser technology could help advance radiotherapy and treat tumors that are resistant to conventional radiotherapy.

Moffitt Cancer Center researchers are working to better understand the molecular mechanisms that promote the development and progression of breast cancer brain metastasis to help improve diagnostics and treatments.

A protein that in single cells helps generate the force needed to move works differently in cells moving in groups, a new study shows.

Researchers at the University of Notre Dame have found that a largely understudied cell could offer new insight into how the aggressive, primary brain cancer is able to resist immunotherapy.

Although immunotherapy has proved disappointing in treating prostate cancer, it may have potential when the cancer starts to spread, as metastatic prostate tumors contain more immune cells.

In the future, a little saliva may be enough to detect an incipient cancer. Researchers at the University of Gothenburg have developed an effective way to interpret the changes in sugar molecules that occur in cancer cells.

Using a liquid biopsy to detect circulating tumor DNA and analyze immune cells helps to predict patient response to immunotherapy in lung cancer patients.